Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19535429 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study)
Condition: Diabetes Mellitus
Interventions: Dietary Supplement: Conjugated Linoleic Acid (CLA);   Dietary Supplement: Safflower OIl

Indicates status has not been verified in more than two years